MDT Q3 2024 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$116B

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8.1B+4.7% YoY

Gross Profit

$5.3B65.6% margin

Operating Income

$1.5B18.3% margin

Net Income

$1.3B16.3% margin

EPS (Diluted)

$0.99

QoQ Revenue Growth

+1.3%

Cash Flow

Operating Cash Flow

$2.5B

Free Cash Flow

$2.1B

Stock-Based Comp.

$84M

Balance Sheet

Total Assets

$90.8B

Total Liabilities

$38.8B

Stockholders' Equity

$51.8B

Cash & Equivalents

$1.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8.1B	$7.7B	+4.7%
Gross Profit	$5.3B	$5.0B	+5.3%
Operating Income	$1.5B	$1.4B	+6.5%
Net Income	$1.3B	$1.2B	+8.2%

Revenue Segments

Cardiac and Vascular Group

$2.9B36%

Neuroscience Group

$2.4B29%

Medical Surgical

$2.1B27%

Diabetes Group

$640M8%

Geographic Segments

UNITED STATES

$4.1B51%

Total Other Countries, Excluding United States and Ireland

$3.9B49%

IRELAND

$27M0%